Literature DB >> 7405765

Paracoccidioidomycosis, neoplasia and associated infections.

R C Leao, E Mendes.   

Abstract

A highly significant percentage of malignancy (8.2%) was found in a group of 147 patients with Paracoccidioidomycosis. Tuberculosis was also observed in 19% of this patient group. The possible immune mechanisms involved in this association are discussed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7405765

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN： 0301-0546            Impact factor:   1.667


  5 in total

Review 1.  Paracoccidioidomycosis in patients with lymphoma and review of published literature.

Authors:  Lucilene Silva Ruiz e Resende; Alice Gadotti Yasuda; Rinaldo Poncio Mendes; Sílvio Alencar Marques; Lígia Niéro-Melo; Júlio Defaveri; Maria Aparecida Custódio Domingues
Journal:  Mycopathologia       Date:  2014-12-20       Impact factor: 2.574

2.  Molecular identification of Paracoccidioides brasiliensis by PCR amplification of ribosomal DNA.

Authors:  A B Motoyama; E J Venancio; G O Brandão; S Petrofeza-Silva; I S Pereira; C M Soares; M S Felipe
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Synchronous oral paracoccidioidomycosis and pulmonary tuberculosis in an immunocompetent patient.

Authors:  Ana Carolina Amorim Pellicioli; Rodrigo Neves-Silva; Alan Roger Santos-Silva; Pablo Agustin Vargas; Márcio Ajudarte Lopes
Journal:  Mycopathologia       Date:  2015-02-05       Impact factor: 2.574

Review 4.  Neoplasia and paracoccidioidomycosis.

Authors:  M A Shikanai-Yasuda; Y M T Conceição; A Kono; E Rivitti; A F Campos; S V Campos
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

5.  Decreasing prevalence of the acute/subacute clinical form of paracoccidioidomycosis in Mato Grosso do Sul State, Brazil.

Authors:  Larissa Rodrigues Fabris; Úrsulla Vilella Andrade; Aline Ferreira Dos Santos; Ana Paula da Costa Marques; Sandra Maria do Valle Leone de Oliveira; Rinaldo Pôncio Mendes; Anamaria Mello Miranda Paniago
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Mar-Apr       Impact factor: 1.846
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.